Filtern
Volltext vorhanden
- ja (10)
Gehört zur Bibliographie
- ja (10)
Dokumenttyp
Sprache
- Englisch (10) (entfernen)
Schlagworte
- nitric oxide (10) (entfernen)
Institut
- Physiologisches Institut (2)
- Abteilung für Parodontologie (in der Poliklinik für Zahnerhaltung und Parodontologie) (1)
- Graduate School of Life Sciences (1)
- Institut für Klinische Biochemie und Pathobiochemie (1)
- Institut für Pharmazie und Lebensmittelchemie (1)
- Julius-von-Sachs-Institut für Biowissenschaften (1)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (1)
- Medizinische Klinik und Poliklinik I (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
EU-Projektnummer / Contract (GA) number
- 241778 (1)
The assessment of the significance of nitrates ingested with food has undergone a fundamental change in recent years after many controversial discussions. While for a long time, a diet as low in nitrates as possible was advocated on the basis of epidemiological data suggesting a cancer-promoting effect of nitrate-rich diets, more recent findings show that dietary nitrate, after its conversion to nitrite by nitrate-reducing bacteria of the oral microbiota, is an indispensable alternative source for the formation of nitric oxide (NO), which comprises a key element in the physiology of a variety of central body functions such as blood pressure control, defense against invading bacteria and maintenance of a eubiotic microbiota in the gut and oral cavity. This compact narrative review aims to present the evidence supported by clinical and in vitro studies on the ambivalent nature of dietary nitrates for general and oral health and to explain how the targeted adjuvant use of nitrate-rich diets could open new opportunities for a more cause-related control of caries and periodontal disease.
The blood-brain barrier (BBB), made up of endothelial cells of capillaries in the brain, maintains the microenvironment of the central nervous system. During ischemia and traumatic brain injury (TBI), cellular disruption leading to mechanical insult results to the BBB being compromised. Oxygen glucose deprivation (OGD) is the most commonly used in vitro model for ischemia. On the other hand, stretch injury is currently being used to model TBI in vitro. In this paper, the two methods are used alone or in combination, to assess their effects on cerebrovascular endothelial cells cEND in the presence or absence of astrocytic factors. Applying severe stretch and/or OGD to cEND cells in our experiments resulted to cell swelling and distortion. Damage to the cells induced release of lactate dehydrogenase enzyme (LDH) and nitric oxide (NO) into the cell culture medium. In addition, mRNA expression of inflammatory markers interleukin (I L)-6, IL-1\(\alpha\) chemokine (C-C motif) ligand 2 (CCL2) and tumor necrosis factor (TNF)-\(\alpha\) also increased. These events could lead to the opening of calcium ion channels resulting to excitotoxicity. This could be demonstrated by increased calcium level in OGD-subjected cEND cells incubated with astrocyte-conditioned medium. Furthermore, reduction of cell membrane integrity decreased tight junction proteins claudin-5 and occludin expression. In addition, permeability of the endothelial cell monolayer increased. Also, since cell damage requires an increased uptake of glucose, expression of glucose transporter glut1 was found to increase at the mRNA level after OGD. Overall, the effects of OGD on cEND cells appear to be more prominent than that of stretch with regards to TJ proteins, NO, glutl expression, and calcium level. Astrocytes potentiate these effects on calcium level in cEND cells. Combining both methods to model TBI in vitro shows a promising improvement to currently available models.
Background:
Recently, we gained evidence that impairment of rOat1 and rOat3 expression induced by ischemic acute kidney injury (AKI) is mediated by COX metabolites and this suppression might be critically involved in renal damage.
Methods:
(i) Basolateral organic anion uptake into proximal tubular cells after model ischemia and reperfusion (I/R) was investigated by fluorescein uptake. The putative promoter sequences from hOAT1 (SLC22A6) and hOAT3 (SCL22A8) were cloned into a reporter plasmid, transfected into HEK cells and (ii) transcriptional activity was determined after model ischemia and reperfusion as a SEAP reporter gen assay. Inhibitors or antagonists were applied with the beginning of reperfusion.
Results:
By using inhibitors of PKA (H89) and PLC (U73122), antagonists of E prostanoid receptor type 2 (AH6809) and type 4 (L161,982), we gained evidence that I/R induced down regulation of organic anion transport is mediated by COX1 metabolites via E prostanoid receptor type 4. The latter signaling was confirmed by application of butaprost (EP2 agonist) or TCS2510 (EP4 agonist) to control cells. In brief, the latter signaling was verified for the transcriptional activity in the reporter gen assay established. Therein, selective inhibitors for COX1 (SC58125) and COX2 (SC560) were also applied.
Conclusion:
Our data show (a) that COX1 metabolites are involved in the regulation of renal organic anion transport(ers) after I/R via the EP4 receptor and (b) that this is due to transcriptional regulation of the respective transporters. As the promoter sequences cloned were of human origin and expressed in a human renal epithelial cell line we (c) hypothesize that the regulatory mechanisms described after I/R is meaningful for humans as well.
Pentacyclic triterpenes from Cecropia telenitida with immunomodulatory activity on dendritic cells
(2013)
Pentacyclic triterpenes are a large family of plant metabolites that exhibit a wide array of biological activities. The genus Cecropia, which encompasses many plant species, has been used as traditional medicine for the treatment of inflammatory diseases and is known to produce many active pentacyclic triterpenes. In this study we investigated the chemical composition of a pentacyclic triterpene fraction from the roots of Cecropia telenitida Cuatrec., Urticaceae. A novel compound, which we termed yarumic acid, and four known molecules (serjanic acid, spergulagenic acid A, 20-hydroxy-ursolic acid and goreishic acid I) were isolated and characterised. In a dendritic cell (DC)-based assay, we demonstrated that non-toxic doses of these pentacyclic triterpenes inhibited the secretion of at least one of the proinflammatory cytokines tested (IL-1 beta, IL-12p40, IL-12p70, TNF-alpha). Spergulagenic acid A also inhibited nitric oxide production in lipopolysaccharide-stimulated dendritic cell. Serjanic acid and spergulagenic acid A, which were the most potent abundant compounds in the pentacyclic triterpene fraction, showed the most activity in the dendritic cell-based assay. These results show that all pentacyclic triterpenes might contribute to the anti-inflammatory activities of C. telenitida. Moreover, yarumic acid as well as the four known pentacyclic triterpenes, can be exploited as potential immunomodulatory/anti-inflammatory agents.
NO has been described as an important component involved in the development of the hypersensitive reaction (Delledonne et.al., 1998). Furthermore, NO induces expression of a set of defence gene, such as PR-1, PAL1 and chalcone synthase (CHS), and accumulation of SA (Durner et al., 1998). In this study, transgenic plants with altered NO levels were used to study the role of NO in plant defence. Arabidopsis plants which, due to expression of a bacterial NO dioxygenase, exhibit lower levels of NO than wild-type plants, show several weakened defence response, including the oxidative burst and expression of phenylpropanoid pathway genes. By contrast, constitutive expression of a bacterial NO synthase in Arabisopsis results in increased levels of endogenous NO. However, these plants do not show constitutively activated defence responses, but suffer from increased susceptibility to various strains of P. syringae. This might indicate that a gradient in NO production rather than constitutive elevation of NO is necessary to trigger plant defence responses. Nevertheless, NO seems to be important for regulation of the oxidative state in plant cells. This function of NO is important during leaf senescence. The data of the present work indicate that NO acts as senescence-delaying factor during plant development. The molecular action of NO in plants and signalling cascades in which NO is involved as second messenger are still poorly understood. Experiments addressing the selective quantification of NO in intact plant tissue, the identification of NO-target proteins as well as the function of NO-modified biomolecules might help to understand the role of NO in plants. Non-host resistance consists of several layers of defence that include preformed compounds existing in plants before pathogen infection and induced defences which the plant activates after recognition of a pathogen. The role of inducible defences in preventing multiplication of non-adapted bacteria is not clear. Our experiments suggest that to restrict non-adapted bacterial growth, pre-formed antimicrobial compounds and an early inducible cell wall-based defence might play an important role in Arabidopsis leaves. Upon inoculation with non-adapted bacteria, we have observed early, TTSS-independent up-regulation of PAL1 and BCB, two lignin biosynthesis genes which might be involved in papilla formation or other kinds of cell wall fortification. Moreover, Arabidopsis pal1 knockout lines permit significantly higher survival of non-adapted bacteria in leaves than wild-type plants, suggesting a functional importance of PAL1 up-regulation. Although non-host bacteria, like host bacteria, induce accumulation of SA and PR gene expression in a TTSS-dependent manner, SA-dependent or JA/ET-dependent defences do not directly contribute to non-host resistance. Moreover, non-adapted bacteria activate similar defence signalling pathways as do host bacteria. However, because of varieties in effector protein composition between different non-adapted bacterial strains, the activated signalling pathways might also include different compounds. The Arabidopsis ecotype Ler 0 is more susceptible to a non-adapted strain of P. syringae than ecotype Col-0. Although differences in glucosinolate content and composition between those ecotypes exist, they are probably not a major reason for the observed difference in non-host resistance. To further understand the mechanisms underlying non-host resistance, the generation of double or triple mutants with deficits in both cell wall-based defences and SA-dependent signal cascades is necessary. Moreover, the study of genome polymorphism and composition of secondary metabolites between Ler-0 and Col-0 can shed new light into the mechanisms of non-host resistance against bacterial pathogens. Additionally, experiments addressing papilla formation and callose biosynthesis in Ler-0 and Col-0 could help to further elucidate bacterial non-host resistance. Our data indicate that localized contact of Arabidopsis leaves with non-adapted bacteria, type III secretion-defective P. syringae strains and bacterial pathogen-associated molecular patterns (PAMPs) induce systemic acquired resistance (SAR) at the whole plant level. This finding contrasts the general belief that an HR or other leaf necroses are required for SAR induction. The observed symptomless systemic response was abolished in all SAR-deficient mutants tested in this study, but was intact in the jar1 mutant, which is compromised in induction of ISR, indicating that non-host bacteria and PAMPs induce SAR in a mechanistically similar way than host bacteria. In addition, our data show that the extent of SA accumulation or PR gene expression induced at sites of virulent or avirulent P. syringae inoculation rather than the amount of tissue necroses or jasmonate accumulation determine the magnitude of SAR. The fact that systemic responses were also triggered after local treatment with type III secretion-defective P. syringae strains and bacterial PAMPs indicate that induction of SAR is TTSS-independent. Instead, recognition of general elicitors like flagellin and LPS play an important role in activation of the SAR process. To broaden the concept of PAMP-based SAR initiation, further general elicitors from bacteria and fungal pathogens should be tested for their capability to induce SAR. Screens for mutants with deficiency in SAR activation by individual PAMPs can help to identify new components involved in the SAR signalling cascade. Possible functions of PAMPs as mobile systemic signals should be tested in future experiments. By selection of candidate genes whose expression is up-regulated in Arabidopsis leaves infected with avirulent and virulent P. syringae and pathophysiological analyses of corresponding T-DNA knockout lines, FLAVIN-DEPENDENT MONOOXYGENASE1 (FMO1) was identified as a key SAR regulator. SAR triggered by P. syringae is completely abolished in fmo1 mutant plants, and pathogen-induced expression of FMO1 in systemic leaves is closely correlated with the capability of different Arabidopsis lines to develop SAR. According to our findings, we have proposed that the FMO1 acts in signal amplification in non-inoculated, systemic leaves to trigger SAR. Experimental verification of the postulated potential amplification cycle underlying SAR should be tested in future experiments. The generation of transgenic lines expressing FMO1::GFP will provide useful information about the cellular localization of the FMO1 protein. Moreover, a comparative metabolomic analysis using SAR-induced wild-type, fmo1 knockout and FMO1 overexpressing lines can be used to identify substrates and reaction products of the FMO1 monooxygenase. As the single yeast FMO (yFMO) provides oxidizing equivalents at the ER for correct protein folding, expression of FMO1 in yfmo mutant yeast combined with protein activity assays might indicate whether FMO1 exhibits functional similarities with yeast FMO, e.g. in assuring proper folding of ER-targeted proteins essential for SAR establishment. Identification of further genes involved in activation of systemic resistance and biochemical characterization of the corresponding proteins can help to understand the SAR process in more detail.
Nitric oxide (NO) binds to soluble guanylyl cyclase (sGC), activates it in a reduced oxidized heme iron state, and generates cyclic Guanosine Monophosphate (cGMP), which results in vasodilatation and inhibition of osteoclast activity. In inflammation, sGC is oxidized and becomes insensitive to NO. NO- and heme-independent activation of sGC requires protein expression of the α\(_1\)- and β\(_1\)-subunits. Inflammation of the periodontium induces the resorption of cementum by cementoclasts and the resorption of the alveolar bone by osteoclasts, which can lead to tooth loss. As the presence of sGC in cementoclasts is unknown, we investigated the α\(_1\)- and β\(_1\)-subunits of sGC in cementoclasts of healthy and inflamed human periodontium using double immunostaining for CD68 and cathepsin K and compared the findings with those of osteoclasts from the same sections. In comparison to cementoclasts in the healthy periodontium, cementoclasts under inflammatory conditions showed a decreased staining intensity for both α\(_1\)- and β\(_1\)-subunits of sGC, indicating reduced protein expression of these subunits. Therefore, pharmacological activation of sGC in inflamed periodontal tissues in an NO- and heme-independent manner could be considered as a new treatment strategy to inhibit cementum resorption.
Myeloid-derived suppressor cells (MDSCs) constitute of monocytic (M-MDSCs) and granulocytic cell subsets (G-MDSCs)and were initially described as suppressors of T-cell function in tumor microenvironments. Recent studies have shown the involvement of MDSCs in a number of infectious diseases including Mycobacterium tuberculosis (Mtb) infection. MDSCs are tremendously accumulated in patients with Mtb infection and exert a suppressive effect on T cell responses against mycobacteria. Mycobacterium bovis BCG, the only available vaccine against Mtb fails to protect against the adult pulmonary tuberculosis (TB). Understanding the mechanisms of MDSC suppression for immunity against mycobacterial infection will provide a rational basis to improve anti- TB vaccination and host-directed therapies against TB. In this study, we investigated the role of three lipid-rich components of the plasma membrane, Caveolin-1(Cav-1), Acid Sphingomyelinase (ASM) and asialo-GM1 on BCG-activated MDSCs.
Cav-1 is one of the vital components of caveolae (plasma membrane invaginations) which regulates apoptosis and lipid metabolism. In this work, we found that MDSCs upregulated Cav-1, TLR4 and TLR2 expression after BCG infection on the cell surface. However, Cav-1 deficiency resulted in a selective defect in the intracellular TLR2 accumulation in the M-MDSC, but not G-MDSC subset. Further analysis indicated no difference in the phagocytosis of BCG by M-MDSCs from WT and Cav1-/- mice but a reduced capacity to up-regulate surface markers, to secrete various cytokines, induce iNOS and NO production. These defects correlated with deficits of Cav1-/- MDSCs in the suppression of T cell proliferation. Among the signaling pathways that were affected by Cav-1 deficiency, we found lower phosphorylation of NF-kB and p38 mitogen-activated protein kinase (MAPK) in BCG - activated MDSCs.
ASM is an enzyme present in lysosomes and is translocated to the cell surface where it hydrolyzes sphingomyelin into ceramide. Flow cytometric studies revealed that MDSCs phagocytosed BCG independent of inhibiting ASMase using pharmacological inhibitors (amitryptiline or desipramine) or MDSCs from WT and ASM-/-. Suppression of ASMase or using ASM-/- MDSCs resulted in reduced NO production and decreased cytokine secretion by MDSCs in response to BCG. Furthermore, MDSCs inhibited by amitryptiline had impaired AKT phosphorylation upon BCG infection.
Asialo-GM1 is a ganglioside expressed on the cell surface of MDSCs reported to cooperate with TLR2 for activating ERK signaling. Here, in this study, we found that asialo-GM1 expression was upregulated specifically upon mycobacterial infection and not upon any other stimulus. We noted that the soluble form of asialo-GM1 bound to BCG. Flow cytometric studies revealed that blocking
81
asialo-GM1 did not affect the phagocytosis of BCG into MDSCs. Furthermore, blocking of asialo- GM1 had no effect on the cytokine and NO secretion or AKT signaling.
Collectively, the data presented in this work implicated that Cav-1, ASM, asialo-GM1 are dispensable for the internalization of BCG. Rather, Cav-1 and ASM are required for the functional activation of MDSCs. Although asialo-GM1 binds to BCG, we did not find any difference in the functional activation of MDSCs after blocking asialo-GM1. This study provides insights into the role of lipid raft components of the MDSC cell membrane during mycobacterial infection.
Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue
(2015)
Obesity is characterized by a positive energy balance and expansion of white adipose tissue (WAT). In contrast, brown adipose tissue (BAT) combusts energy to produce heat. Here we show that a small molecule stimulator (BAY 41-8543) of soluble guanylyl cyclase (sGC), which produces the second messenger cyclic GMP (cGMP), protects against diet-induced weight gain, induces weight loss in established obesity, and also improves the diabetic phenotype. Mechanistically, the haeme-dependent sGC stimulator BAY 41-8543 enhances lipid uptake into BAT and increases whole-body energy expenditure, whereas ablation of the haeme-containing \(\beta\)\(_{1}\)-subunit of sGC severely impairs BAT function. Notably, the sGC stimulator enhances differentiation of human brown adipocytes as well as induces 'browning' of primary white adipocytes. Taken together, our data suggest that sGC is a potential pharmacological target for the treatment of obesity and its comorbidities.
Background
Direct interaction between Red blood cells (RBCs) and platelets is known for a long time. The bleeding time is prolonged in anemic patients independent of their platelet count and could be corrected by transfusion of RBCs, which indicates that RBCs play an important role in hemostasis and platelet activation. However, in the last few years, opposing mechanisms of platelet inhibition by RBCs derived nitric oxide (NO) were proposed. The aim of our study was to identify whether RBCs could produce NO and activate soluble guanylate cyclase (sGC) in platelets.
Methods
To test whether RBCs could activate sGC under different conditions (whole blood, under hypoxia, or even loaded with NO), we used our well-established and highly sensitive models of NO-dependent sGC activation in platelets and activation of purified sGC. The activation of sGC was monitored by detecting the phosphorylation of Vasodilator Stimulated Phosphoprotein (VASPS239) by flow cytometry and Western blot. ANOVA followed by Bonferroni’s test and Student’s t-test were used as appropriate.
Results
We show that in the whole blood, RBCs prevent NO-mediated inhibition of ADP and TRAP6-induced platelet activation. Likewise, coincubation of RBCs with platelets results in strong inhibition of NO-induced sGC activation. Under hypoxic conditions, incubation of RBCs with NO donor leads to Hb-NO formation which inhibits sGC activation in platelets. Similarly, RBCs inhibit activation of purified sGC, even under conditions optimal for RBC-mediated generation of NO from nitrite.
Conclusions
All our experiments demonstrate that RBCs act as strong NO scavengers and prevent NO-mediated inhibition of activated platelets. In all tested conditions, RBCs were not able to activate platelet or purified sGC.
The human-pathogenic bacterium Salmonella enterica adjusts and adapts to different environments while attempting colonization. In the course of infection nutrient availabilities change drastically. New techniques, "-omics" data and subsequent integration by systems biology improve our understanding of these changes. We review changes in metabolism focusing on amino acid and carbohydrate metabolism. Furthermore, the adaptation process is associated with the activation of genes of the Salmonella pathogenicity islands (SPIs). Anti-infective strategies have to take these insights into account and include metabolic and other strategies. Salmonella infections will remain a challenge for infection biology.